This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2.SE Cosgrove . Evidence that prevention makes cents: costs of catheter-associated bloodstream infections in the intensive care unit. Critical Care Medicine 2006; 34: 2243–2244.
Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992–2003. Clinical Infectious Diseases
2006; 42: 389–391.
5.DW MacPherson , Population mobility, globalization, and antimicrobial drug resistance. Emerging Infectious Diseases 2009; 15: 1727–1732.
6.BA Rogers , Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clinical Infectious Diseases 2011; 53: 49–56.
. Infectious disease morbidity in the US region bordering Mexico, 1990–1998. Journal of Infectious Diseases
2000; 182: 1503–1510.
. Cross-border utilization of health care services by United States residents living near the Mexican border. Revista Panamericana de Salud Publica
2009; 26: 95–100.
11.GC de Guzman , A survey of the use of foreign-purchased medications in a border community emergency department patient population. Journal of Emergency Medicine 2007; 33: 213–221.
Public health surveillance using emergency medical service logs – U.S.–Mexico land border, El Paso, Texas, 2009. Morbidity and Mortality Weekly Report
2010; 59: 649–653.
Study of methicillin-resistant Staphylococcus aureus on the U.S./Mexico border. Travel Medicine and Infectious Disease
2009; 7: 30–34.
14.FG O'Brien , Survey of methicillin-resistant Staphylococcus aureus strains from two hospitals in El Paso, Texas. Journal of Clinical Microbiology 2005; 43: 2969–2972.
15.M Weinberg , The U.S.-Mexico Border Infectious Disease Surveillance project: establishing bi-national border surveillance. Emerging Infectious Diseases 2003; 9: 97–102.
17.GV Sanchez , In Vitro Antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrobial Agents and Chemotherapy 2012; 56: 2181–2183.
Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. American Journal of Medicine
2008; 121: 876–884.
19.National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. American Journal of Infection Control 2004; 32: 470–485.
21.SK Fridkin , Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine 2005; 352: 1436–1444.
22.AL Hersh , National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Archives of Internal Medicine 2008; 168: 1585–1591.
23.U Seybold , Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clinical Infectious Diseases 2006; 42: 647–656.
Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997–2007. Journal of the American Medical Association
2009; 301: 727–736.
26.DJ Diekema , Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clinical Infectious Diseases 2004; 38: 78–85.
28.MH Kyaw , Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. New England Journal of Medicine 2006; 354: 1455–1463.
Shifting genetic structure of invasive serotype 19A pneumococci in the United States. Journal of Infectious Diseases
2011; 203: 1360–1368.
30.AC Nyquist , Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. Journal of the American Medical Association 1998; 279: 875–877.
Use of antibiotics in upper respiratory infections on patients under 16 years old in private ambulatory medicine. Salud Publica de Mexico
2003; 45: 159–164.
. Current antibiotic therapy for isolated urinary tract infections in women. Archives of Internal Medicine
2006; 166: 635–639.
33.C Gagliotti , Emergence of ciprofloxacin resistance in Escherichia coli isolates from outpatient urine samples. Clinical Microbiology and Infection 2007; 13: 328–331.
34.AN Ortega , Health care access, use of services, and experiences among undocumented Mexicans and other Latinos. Archives of Internal Medicine 2007; 167: 2354–2360.
35.D Yong , Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrobial Agents and Chemotherapy 2009; 53: 5046–5054.
38.A Dreser , Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation. BMC Public Health 2012; 12: 1051.